Diabetic kidney disease 2.0: the treatment paradigm shifts

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The lancet. Diabetes & endocrinology 2019-11, Vol.7 (11), p.820-821
1. Verfasser:	Gilbert, Richard E
Format:	Artikel
Sprache:	eng
Schlagworte:	Diabetes Mellitus, Type 2 Diabetic Nephropathies Humans Renal Insufficiency Sodium-Glucose Transporter 2 Inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	821
container_issue	11
container_start_page	820
container_title	The lancet. Diabetes & endocrinology
container_volume	7
creator	Gilbert, Richard E
description
doi_str_mv	10.1016/S2213-8587(19)30253-0
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2287524770</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2213858719302530</els_id><sourcerecordid>2287524770</sourcerecordid><originalsourceid>FETCH-LOGICAL-c365t-7b37b542445c770fb139268b37d4b0a3d83e8d8765d779a6fda82a91f4394ed3</originalsourceid><addsrcrecordid>eNqFkMlOwzAQhi0EolXpI4ByLIcUL3Fs94JQWaVKHOjdcuwJNTRNsV2kvj3pAldOMxr9i-ZD6JLgMcGkvHmjlLBccilGRF0zTDnL8QnqH8-Kn_7tUvTQMMYPjDHBnJUSn6MeI4XiJcd9NLn3poLkbfbp3Qq2mfMRTISMjvEkSwvIUgCTGlilbG2Ccf69yeLC1yleoLPaLCMMj3OA5o8P8-lzPnt9epnezXLLSp5yUTFR8YIWBbdC4LoiTNFSdldXVNgwJxlIJ0XJnRDKlLUzkhpF6oKpAhwboNEhdh3arw3EpBsfLSyXZgXtJmpKpeC06KI7KT9IbWhjDFDrdfCNCVtNsN6B03twekdFE6X34PTOd3Ws2FQNuD_XL6ZOcHsQQPfnt4ego_WwsuB8AJu0a_0_FT9yA3rA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2287524770</pqid></control><display><type>article</type><title>Diabetic kidney disease 2.0: the treatment paradigm shifts</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Gilbert, Richard E</creator><creatorcontrib>Gilbert, Richard E</creatorcontrib><identifier>ISSN: 2213-8587</identifier><identifier>EISSN: 2213-8595</identifier><identifier>DOI: 10.1016/S2213-8587(19)30253-0</identifier><identifier>PMID: 31495650</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Diabetes Mellitus, Type 2 ; Diabetic Nephropathies ; Humans ; Renal Insufficiency ; Sodium-Glucose Transporter 2 Inhibitors</subject><ispartof>The lancet. Diabetes & endocrinology, 2019-11, Vol.7 (11), p.820-821</ispartof><rights>2019 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c365t-7b37b542445c770fb139268b37d4b0a3d83e8d8765d779a6fda82a91f4394ed3</citedby><cites>FETCH-LOGICAL-c365t-7b37b542445c770fb139268b37d4b0a3d83e8d8765d779a6fda82a91f4394ed3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31495650$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gilbert, Richard E</creatorcontrib><title>Diabetic kidney disease 2.0: the treatment paradigm shifts</title><title>The lancet. Diabetes & endocrinology</title><addtitle>Lancet Diabetes Endocrinol</addtitle><subject>Diabetes Mellitus, Type 2</subject><subject>Diabetic Nephropathies</subject><subject>Humans</subject><subject>Renal Insufficiency</subject><subject>Sodium-Glucose Transporter 2 Inhibitors</subject><issn>2213-8587</issn><issn>2213-8595</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMlOwzAQhi0EolXpI4ByLIcUL3Fs94JQWaVKHOjdcuwJNTRNsV2kvj3pAldOMxr9i-ZD6JLgMcGkvHmjlLBccilGRF0zTDnL8QnqH8-Kn_7tUvTQMMYPjDHBnJUSn6MeI4XiJcd9NLn3poLkbfbp3Qq2mfMRTISMjvEkSwvIUgCTGlilbG2Ccf69yeLC1yleoLPaLCMMj3OA5o8P8-lzPnt9epnezXLLSp5yUTFR8YIWBbdC4LoiTNFSdldXVNgwJxlIJ0XJnRDKlLUzkhpF6oKpAhwboNEhdh3arw3EpBsfLSyXZgXtJmpKpeC06KI7KT9IbWhjDFDrdfCNCVtNsN6B03twekdFE6X34PTOd3Ws2FQNuD_XL6ZOcHsQQPfnt4ego_WwsuB8AJu0a_0_FT9yA3rA</recordid><startdate>201911</startdate><enddate>201911</enddate><creator>Gilbert, Richard E</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201911</creationdate><title>Diabetic kidney disease 2.0: the treatment paradigm shifts</title><author>Gilbert, Richard E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c365t-7b37b542445c770fb139268b37d4b0a3d83e8d8765d779a6fda82a91f4394ed3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Diabetes Mellitus, Type 2</topic><topic>Diabetic Nephropathies</topic><topic>Humans</topic><topic>Renal Insufficiency</topic><topic>Sodium-Glucose Transporter 2 Inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gilbert, Richard E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The lancet. Diabetes & endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gilbert, Richard E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diabetic kidney disease 2.0: the treatment paradigm shifts</atitle><jtitle>The lancet. Diabetes & endocrinology</jtitle><addtitle>Lancet Diabetes Endocrinol</addtitle><date>2019-11</date><risdate>2019</risdate><volume>7</volume><issue>11</issue><spage>820</spage><epage>821</epage><pages>820-821</pages><issn>2213-8587</issn><eissn>2213-8595</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>31495650</pmid><doi>10.1016/S2213-8587(19)30253-0</doi><tpages>2</tpages></addata></record>
fulltext	fulltext
identifier	ISSN: 2213-8587
ispartof	The lancet. Diabetes & endocrinology, 2019-11, Vol.7 (11), p.820-821
issn	2213-8587 2213-8595
language	eng
recordid	cdi_proquest_miscellaneous_2287524770
source	MEDLINE; Alma/SFX Local Collection
subjects	Diabetes Mellitus, Type 2 Diabetic Nephropathies Humans Renal Insufficiency Sodium-Glucose Transporter 2 Inhibitors
title	Diabetic kidney disease 2.0: the treatment paradigm shifts
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T14%3A09%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diabetic%20kidney%20disease%202.0:%20the%20treatment%20paradigm%20shifts&rft.jtitle=The%20lancet.%20Diabetes%20&%20endocrinology&rft.au=Gilbert,%20Richard%20E&rft.date=2019-11&rft.volume=7&rft.issue=11&rft.spage=820&rft.epage=821&rft.pages=820-821&rft.issn=2213-8587&rft.eissn=2213-8595&rft_id=info:doi/10.1016/S2213-8587(19)30253-0&rft_dat=%3Cproquest_cross%3E2287524770%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2287524770&rft_id=info:pmid/31495650&rft_els_id=S2213858719302530&rfr_iscdi=true